Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance

por Hing, J.X., Mok, C.W., Tan, P.T., Sudhakar, S.S., Seah, C.M., Lee, W.P., Tan, S.M.
Publicado 2020